Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease.
Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease. Nat Commun. 2019 01 18; 10(1):310.
View in:
PubMed
subject areas
Aged
Aged, 80 and over
Animals
Antiparkinson Agents
Bacteria
Female
Gastrointestinal Microbiome
Humans
Intestine, Small
Levodopa
Male
Middle Aged
Parkinson Disease
Rats
Tyrosine Decarboxylase
authors with profiles
Ali Keshavarzian